Acadia Healthcare Company, Inc. (ACHC)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-04-29

Key Insights

Acadia reported Q1 2026 results on April 29, 2026, with earnings and operational metrics disclosed through press release and investor conference call scheduled for April 30, 2026, indicating routine quarterly earnings announcement.
The company faces significant regulatory headwinds from the One Big Beautiful Bill Act (OBBBA) enacted July 4, 2025, which introduces work/community engagement requirements for Medicaid expansion patients and changes Medicaid financing mechanisms, creating material risk to future payment volumes and revenue.
Forward-looking statement risks highlight integration challenges from acquisitions, potential operational disruptions, cybersecurity threats, and labor/supply chain cost pressures that could materially impact future financial performance and cash flow generation.

Insider Trading Filed: 2026-04-13

Key Insights

The reporting person, Brian Farley, acquired 37,510 shares of Acadia Healthcare Company, Inc. (ACHC) common stock at no cost, indicating an equity compensation award such as restricted stock units or stock options.
The award will vest over a 3-year period in equal yearly installments beginning April 10, 2027, aligning Farley's incentives with long-term shareholder value creation.
Insider buying can be a positive signal, as it suggests management's confidence in the company's prospects, though the size of the transaction is relatively small compared to Farley's existing stake of 106,675 shares.

Insider Trading Filed: 2026-04-13

Key Insights

Todd S. Young, the Chief Financial Officer of Acadia Healthcare Company, Inc., has acquired 58,799 shares of the company's common stock, further aligning his interests with those of shareholders.
The shares acquired will vest over a 3-year period in equal yearly installments, indicating a long-term commitment from the CFO to the company's success.
Insider buying, especially by a C-suite executive, is generally seen as a positive signal for the company's future prospects and may boost investor confidence.

Current Report Filed: 2026-01-23

Key Insights

Acadia Healthcare's CEO Christopher H. Hunter has departed the company, effective January 20, 2026.
Mr. Hunter will receive separation benefits including a cash severance payment, continued health insurance coverage, and a prorated portion of his outstanding performance-based restricted stock units.
The separation agreement includes a release of claims in favor of Acadia and restrictive covenants for Mr. Hunter.

Insider Trading Filed: 2026-01-21

Key Insights

Debra K. Osteen, the Chief Executive Officer of Acadia Healthcare Company, Inc. (ACHC), has been granted a stock option to acquire 1,125,000 shares of the company's common stock, with vesting conditions tied to various stock price targets.
The vesting of the stock option is structured to incentivize Osteen to drive the company's stock price higher, with the first tranche of 250,000 shares vesting when the 30-day share price VWAP (volume-weighted average price) reaches $25.00, and subsequent tranches vesting at $35.00 and $45.00 share price targets.
The option grant reflects the company's commitment to aligning executive compensation with shareholder interests and long-term performance, as the vesting is dependent on the achievement of specific stock price milestones.

Current Report Filed: 2026-01-20

Key Insights

Acadia Healthcare Company announced the departure of its Chief Executive Officer, Christopher H. Hunter, effective January 20, 2026.
The Board appointed Debra K. Osteen as the new Chief Executive Officer, effective the same date. Osteen previously served as CEO from 2018 to 2022.
Osteen's employment agreement includes a base salary of $1,061,000, an annual cash bonus target of 125% of base salary, and an initial equity award of stock options.

Current Report Filed: 2026-01-13

Key Insights

Acadia Healthcare is reaffirming its 2025 financial guidance, providing investors with confidence in the company's performance expectations.
The company is discussing information on slides during its presentation at the 44th Annual J.P. Morgan Healthcare Conference, which could provide insight into its strategic priorities and outlook.
Potential risks identified include difficulties in integrating acquired facilities, reductions in government and commercial payor payments, and disruptions to the company's information technology systems.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.